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Abstract 
 
Isothiazolones and 5-chloroisothiazolones chemoselectively react with thiols by cleavage of the 
weak nitrogen-sulfur bond to form disulfides. They show selectivity for inhibition of the thiol -
dependent cysteine protease cathepsin B and the histone acetyltransferase p300/CBP associated 
factor (PCAF) based on their substitution pattern. Furthermore, enzyme kinetics and mass 
spectrometry indicate covalent binding a 5-chloroisothiazolone to cathepsin B, which 
demonstrates their potential utility as probes for activity-based protein profiling. 
  
      105     
 
Isothiazolones; thiol-reactive inhibitors of  
cysteine protease cathepsin B and histone acetyl transferase 
Introduction 
Functional groups that react covalently with thiolates have been used extensively for activity-
based protein profiling of cysteine-proteases.1 This technology depends on covalent labelling of 
active site thiolates of enzymes in cell-lysates. Labelling is often performed with biotinylated 
functionalities, which can be employed for purification with immobilized streptavidin. Cleavable 
inhibitor-biotin linkers have been developed to improve the recovery of the proteins of interest. 2 
Our current study indicates that isothiazolones and 5-chloroisothiazolones are excellent 
candidates for this purpose, because the disulfides that are formed upon reaction with active site 
thiolates (Scheme 1) can be cleaved under mild conditions.  
 The activity of isothiazolones and 5-chloroisothiazolones is expected to originate for a major 
extend from the reactivity of these heterocycles towards thiolates.3 In a careful study, Alvarez-
Sánchez et al.4 described that N-methyl-5-chloroisothiazolone reacts with oxygen and nitrogen 
nucleophiles via an addition-elimination in the 5-position, thereby substituting the chloride. 
Treatment of N-methyl-5-chloroisothiazolone with thiol-nucleophiles, however, provided ring-
opened thioester and dithioester products that can not be explained this way. This indicates that 
the thiol nucleophiles react through cleavage of the N-S bond (Scheme 1). 
 Cathepsin B is a biologically relevant enzyme that is implicated in tumor formation, 
angiogenesis, tumor invasion and metastasis.5, 6 Furthermore, cathepsin B has be been considered 
as a potentical biomarker for prognosis in cancer.7 Biotinylated irreversible inhibitors can be used 
as a probe in activity-based protein profiling of cathepsin B.8, 9 In this study we identify 
isothiazolones and 5-chloroisothiazolones as covalent inhibitors of cathepsin B. Furthermore, we 
evaluated the selectivity of cathepsin B inhibition compared to the histone acetyltransferase 
(HAT) p300/CBP associated factor (PCAF). This enzyme plays a role in the Nuclear Factor κ B 
inflammation.10 Upon activation, NFκB binds to cofactors that have intrinsic HAT activity, like  
PCAF, which in turn acetylate lysines in core histone H4.11 This leads to a less compact 
chromatin structure, which enables the transcription of proinflammatory genes, including 
Interleukin 8 (IL-8).12, 13 Isothiazolones and 5-chloroisothiazolones (Scheme 1) are potent and 
cell-permeable inhibitors of PCAF, and attempts to optimize their inhibitory activity have been 
made in several studies.14-17 However, their mode of action, selectivity and activity in cell-based 
studies remain to be investigated.  
 Herein we describe isothiazolones, 5-chloroisothiazolones and 5-chloroisothiazolone-1-oxides 
as new classes of cathepsin B inhibitors. Selectivity between cathepsin B and PCAF inhibition 
can be obtained by variation of the substitution. 5-chloroisothiazolones are shown to be non-
competitive inhibitors of cathepsin B and mass spectroscopy demonstrates covalent binding. The 
reaction products of isothiazolones and 5-chloroisothiazolones that are formed upon thiolate 
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treatment proved to be disulfides, which could be advantageous in activity-based protein 
profiling. Futhermore, the most potent PCAF inhibitor is evaluated in a cell -based study for 
inhibition of histone acetylation in comparison to the known HAT inhibitor anacardic acid.  
 
Scheme 1. Reaction of isothiazolones and 5-chloroisothiazolones with propane-1-thiolate results in 
cleavage of the N-S bond. a) propane-1-thiol, Et3N, CH2Cl2 b) extended reaction times resulted in 
hydrolysis of 7. 
Results and discussion 
Synthesis 
Compounds 1, 5 and 11 were prepared by reaction of the corresponding primary amines with 
3,3’-dithiobispropionyl chloride to yield the 3,3’-dithiobispropionic amides as described 
previously for compounds 9, 10, 12-18 and 19-26.15, 16 These amides were treated with 3 equiv. of 
sulfuryl chloride in dichloromethane to yield a mixture of the 5-chloroisothiazolone and the 
isothiazolone, which were separated by column chromatography. 
Thiolate reactivity of (5-chloro)isothiazolones 
The reaction products that are formed upon treatment with thiolates were identified in order to 
study the thiol-reactivity of isothiazolones and 5-chloroisothiazolones. Isothiazolones 1 and 2 
were treated with 1.0 equiv. of propane-1-thiol and triethylamine in dichloromethane (Scheme 1). 
The resulting products were isolated and characterized by NMR and mass analysis. In substrate 1 
the observed 3J(H4,H5) is 6.5 Hz, whereas in product 3 it amounts to 14.1 Hz. Comparably, in 2 
3J(H4,H5) is 6.5 Hz, whereas it is 9.7 Hz in 4. This is a strong indication for an E-configuration of 
the double bond in 3 and 4, which could be caused by a catalytic amount of thiol that reacts via 
subsequent addition, rotation and elimination. When 5-chloroisothiazolones 5 and 6 were 
subjected to the same reaction conditions, 7 was isolated upon treatment of 5, however we were 
not able to isolate a comparable product after treatment of 6. Upon extended reaction times for 
the formation of 7, a new product 8 was isolated that turned out to be the hydrolysis product of 7. 
The 1H and 13C NMR spectra of 8 show two isomers most likely due to keto-enol tautomerism. 
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Figure 1. Three resonance structures of 1. 
         
Figure 2. Crystal structure of 2-phenylisothiazolone 1 (A) and 5-chloro-2-phenylisothiazolone 5 (B). 
CCDC 763228 & 763229 contain the supplementary crystallographic data for this paper. These data can be 
obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html.  





Literature values                             
sp2 a
Literature values                                      
sp3 a
Cl C1 1.7084(18) 1.76
S N 1.715(4) 1.7038(15) 1.56 1.78
1.70 (thiophene)b
1.61
O C3 1.243(6) 1.231(2) 1.23-1.24  (amides) 1.42-1.44   (ethers)
N C3 1.401(7) 1.396(2) 1.35 (imines) 1.46-1.48   (amines)
N C4 1.433(7) 1.433(2) 1.35 (imines) 1.46-1.48   (amines)
C1 C2 1.345(7) 1.346(3) 1.31-1.34 (alkene)
C2 C3 1.452(7) 1.454(3)
1.45-1.46                                
(single conjugated)
C4 C5 1.399(7) 1.396(3) 1.38-1.40 (aromatic)
C4 C9 1.408(7) 1.393(3) 1.38-1.40 (aromatic)
C5 C6 1.383(7) 1.384(3) 1.38-1.40 (aromatic)
C6 C7 1.391(8) 1.395(3) 1.38-1.40 (aromatic)
C7 C8 1.402(8) 1.392(3) 1.38-1.40 (aromatic)
C8 C9 1.374(9) 1.389(3) 1.38-1.40 (aromatic)
1.81S C1 1.702(6) 1.7269(18)
 
Standard uncertainty in the last decimal place is given in parentheses 
a18  , b CCDC 617103 
 The reactivity of isothiazolones originates from the electronic structure of the heterocycle, 
which is supposed to have considerable aromatic character. This is illustrated by resonance 
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structure II and III in Figure 1. To provide experimental evidence for  the aromaticity of 
isothiazolones, the crystal structures of 1 and 5 were resolved (Figure 2, Table 1, CCDC 763228 
and 763229). The numbering of the carbon atoms in the crystal structure deviates from the 
IUPAC numbering in Scheme 1. The crystal structure shows a planar isothiazolone ring for both 
1 and 5. In comparison with literature data (Table 1) the C1-C2 bond length fits to a double bond, 
C2-C3 fits to a single, conjugated bond and C3-O to a double bond. This indicates that resonance 
structure I has a major contribution and that the S-N bond length has single bond character. 
Nevertheless, the C3-N bond is shorter than expected for a single bond and the C1-S bond is also 
shorter than observed for a single bond, which indicates that resonance structures II and III also 
contribute to the structure. 
 The observation that thiol nucleophiles attack isothiazolones on the sulfur can be explained by 
the strength of the formed sulfur-sulfur bond and the weakness of the sulfur-nitrogen bond. In 
contrast, isothiazolones are non-reactive towards oxygen or nitrogen nucleophiles, whereas 5-
chloroisothiazolones react with these nucleophiles via addition-elimination at the 5-position.4  
Cathepsin B and PCAF inhibition 
Cathepsin B inhibition was evaluated by the cleavage of 7-amino-4-methoxy coumarin (AMC) 
from the substrate Cbz-Arg-Arg-AMC.18 Inhibiting concentration (IC50) values were derived after 
15 minutes of pre-incubation with the inhibitors (Table 2). Since these inhibitors are expected to 
interact covalently with the enzyme, differences in potency reflect changes in enzyme binding as 
well as differences in the reaction rate of covalent binding to the enzyme. The assay for the HAT 
PCAF inhibition and the IC50 values of 9, 10, 12-18 and 19-26 have been reported previously.
15, 16  
 Disulfides 3, 4, and 7, isothiazolone 12 and 5-chloroisothiazolone 5 inhibit cathepsin B, whereas 
no inhibition of PCAF is observed in the applied concentrations. Remarkably, disulfide 7 showed the 
highest potency for cathepsin B (46 nM). Isothiazolone 9 inhibits the HAT PCAF, whereas cathepsin 
B is not inhibited, which demonstrates that selective PCAF inhibition can be obtained with N-aryl 
substituents. This is not observed for N-aliphatic substituted isothiazolones and 5-
chloroisothiazolones 12-18. Substitution in the isothiazolone 4-position (R2), in 14, 15 and 16, 
changed the cathepsin B inhibition modestly. Remarkably, N-aliphatic substituted 5-
chloroisothiazolone 11 was more potent for cathepsin B than the other N-aliphatic substituted 5-
chloroisothiazolones. Furthermore, 5-chloroisothiazolone-1-oxides also inhibit cathepsin B (Table 2) 
and their potency also depends on their substitution pattern. Taking these data together it is concluded 
that isothiazolones, 5-chloroisothiazolones and 5-chloroisothiazolone-1-oxides are inhibitors of 
cathepsin B and the HAT PCAF and that their potency and selectivity depends on the substitution in 
the 2-, 4- and 5-position. 
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Table 2. IC50 values for inhibition of cathepsin B and PCAF by isothiazolones, 5-chloroisothiazolones, 
disulfides (Scheme 1), and 5-chloroisothiazolone-1-oxides  
1 H H phenyl >100 >10
3
* H H phenyl 12 ± 1 >10
4
* H H -(CH2)5CO2Me 24 ± 1 >10
5 Cl H -phenyl 13 ± 1 >10
7
* Cl H -phenyl 0.046 ± 0.002 >10
9 H H 3-Cl-4-F-phenyl >100 4.2 ± 0.6
10 Cl H 3-Cl-4-F-phenyl 42 ± 2 2.5 ± 0.1
12 H H -pentyl 13 ± 1 >10
13 Cl H -pentyl 7.3 ± 0.5 2.9 ± 0.3
14 Cl H -(CH2)2CO2Me 12 ± 1 1.8 ± 0.2
15 Cl Cl -(CH2)2CO2Me 8.5 ± 0.7 2.6 ± 0.6
16 Cl CH3 -(CH2)2CO2Me 11 ± 1 >10
17 Cl H -(CH2)2CO2Et 14 ± 2 2.0 ± 0.2
18 Cl H -(CH2)3CO2Me 11 ± 1 2.5 ± 0.3
19 Cl H -Ethyl 27.4 ± 1.1 >10
20 Cl Cl -Ethyl 39.0 ± 0.5 >10
21 Cl CH3 -Ethyl 17.4 ± 1.3 >10
22 Cl H -(CH2)2CO2Me 21.3 ± 1.5 5.6 ± 0.2
23 Cl Cl -(CH2)2CO2Me 34.5 ± 1.2 >10
24 Cl CH3 -(CH2)2CO2Me 23.1 ± 3.1 >10
R3






a          
(µM)
PCAF
b           
(µM)
 
a maximal concentration in the assay 100 M. 
b maximal concentration in the assays 10 M  
* Disulfide compounds as shown in Scheme 1 
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Figure 3. Conversion of the substrate Cbz-Arg-Arg-AMC by the cathepsin B enzyme shows substrate 
inhibition at high substrate concentrations with (A) Inhibitor 5 : (▲) with no inhibitor present, (●) after 
preincubation with 7 M inhibitor 5  and (■) after preincubation with 14 M inhibitor 5; (B) Inhibitor 14 : 
(▲) with no inhibitor present, (●) after preincubation with 6 M inhibitor 14  and (■) after preincubation 
with 12 M inhibitor 14; (C) Inhibitor 22 : (▲) with no inhibitor present, (●) after preincubation with 11 
M inhibitor 22  and (■) after preincubation with 22 M inhibitor 22. The data were fitted to equation 1 
and the parameters are shown in Table 3.  
 
Scheme 2. Enzyme kinetics influence by substrate inhibition 
       equation 1 
Figure 4. Equation for non-linear curve fitting of enzyme kinetics that is influenced by substrate inhibition 
according to the model in Scheme 220 v is the reaction velocity, Vmax is the maximal reaction velocity, [S] 
is the substrate concentration and Km is the Michaelis-Menten constant. Ks is the binding constant of a 
second substrate molecule to the enzyme substrate complex resulting in inhibition of the enzyme activity.  
(B) (A) 
(C) 
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Table 3 Enzyme kinetics parameters for cathepsin B inhibition (n = 3) 
 To establish the mechanism of cathepsin B inhibition further, the influence of inhibitors 5 and 
14 on the Michaelis-Menten kinetics for conversion of the substrate Cbz-Arg-Arg-AMC was 
determined. Cathepsin B conversion of Cbz-Arg-Arg-AMC shows a strong substrate inhibition at 
higher concentrations (Figures 3A-C). Substrate inhibition of the enzyme activity is expected to 
obey the model in Scheme 2 from which the kinetic parameters can be derived by non-linear 
curve fitting of equation 1 (Figure 4). Inhibitor 5 causes a reduced Vmax and a constant Km and Ks 
(Table 3). The same is observed for 14 (Figure 3B, Table 3), whereas the data for 22 did not fit 
well to equation 1 (Figure 3C, Table 3). This result indicates non-competitive inhibition of the 
cathepsin B activity by 5-chloroisothiazolones. Inhibition of cathepsin B activity by 5 proved to 
be time dependent (Table 4) and dilution experiments did not show reactivation of cathepsin B 
(Table 5). Pre-steady state kinetic analysis revealed a very fast inactivation of the enzyme (50% 
inhibition after 20 seconds by 14 M 5, Table 6). The IC50 value proved to decrease slightly over 
time. This result suggests a fast initial binding event followed by a slow second binding event 
(Table 4, 6).  
 Furthermore, mass-spectrometry experiments showed an increased mass after incubation of 
cathepsin B with the inhibitor. The mass spectrometry data showed that the inhibitor can bind one 
or two times to the enzyme. The mass spectrum of the non-reacted enzyme (Figure 5A) gives m/z 
27960 as the [M+H]+ peak and 13985 as the [M+2H]2+ peak. The mass spectrum of the enzyme 
pre-incubated with the inhibitor (Figure 5B) gives m/z 28111 and 28354 as the [M+H]+ and 
14082 and 14177 as the [M+H]2+ peaks. The difference between reacted and non-reacted enzyme 
is 151 and 394 for the [M+H]+ peaks and 97 and 192 for the [M+H]2+ peaks, This indicates that 5-
chloroisothiazolone 5 binds once or twice to the enzyme to give a product corresponding to 8, 
which would mean a mass increase of 194 or 388. Taken these experiments together it is 
concluded that the 5-chloroisothiazolone 5 binds covalently to the thiolate in the enyme active 
[inhibitor] (µM) Vmax (nmol/s) Km (mM) KS (mM) R2
0 0.60 ± 0.41 1.2 ± 0.92 0.11 ± 0.087 0.996
7 0.36 ± 0.20 1.1 ± 0.68 0.11 ± 0.068 0.996
14 0.22 ± 0.10 1.1 ± 0.60 0.12 ± 0.069 0.997
0 0.65 ± 0.66 1.2 ± 1.3 0.10 ± 0.11 0.989
6 0.51 ± 0.24 1.4 ± 0.7 0.10 ± 0.051 0.998
12 0.23 ± 0.13 1.2 ± 0.7 0.20 ± 0.13 0.995
0 0.56 ± 0.67 1.1 ± 1.4 0.098 ± 0.13 0.982
11 0.52 ± 0.59 1.1 ± 1.2 0.11 ± 0.15 0.972
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site and/or to another surface exposed cysteine of cathepsin B. 
Table 4. Time dependent inhibition of cathepsin B by 5. The IC50 of the residual enzyme activity was 
determined after 1, 15, 40 or 120 minutes pre-incubation of the enzyme with the inhibitor (n = 3). 
Time (min) IC50 (µM)
1 13.6 ± 1.5
15 12.7 ± 1.3
40 9.3 ± 1.1
120 8.1 ± 1.0
 
Table 5. Dilution experiments after pre-incubation of Cathepsin B (20 nM) and inhibitor 5 (17 µM) with a 
substrate solution (100 µM) demonstrates a reduction of activity that is proportional to the dilution. This 
demonstrates covalent binding of the enzyme to the inhibitor (n = 3) 6. 
Dilution v (fluorescence units/min) Reduction in activity
1 13.3 ± 0.5 1.00
2 6.9 ± 0.1 1.93
5 2.7 ± 0.1 4.93
 
Table 6. Reduction rate of cathepsin B by 5. The initial rate of cathepsin B (1.5 nM) activity with or without 
inhibitor 5 (14 µM) were determine after 20 second reaction of the enzyme with the substrate (33.3 µM) (n = 3). 
The result shows a very quick reduction of the enzyme activity in presence of the inhibitor.  
Inhibitor V (fluorescence units/s)
No inhibitor 25.3 ± 1.2
 5 (14 µM) 11.9 ± 5.0
 
 
Figure 5. MALDI – TOF mass spectrum of the non-reacted cathepsin B (A) and the mass spectrum of the 
cathepsin B that was pre-incubated with inhibitor 5 (B).  
  
(B) (A) 
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Inhibition of histone acetylation 
The most potent PCAF inhibitor 14 was evaluated in a cell-based assay for inhibition of histone 
acetylation in HEP-G2 cells. To study inhibition of acetylation, deacetylation was blocked by 
treatment with the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Inhibition of 
histone deacetylation by treatment with 10 µM of SAHA for 20 h gave a significant increase in 
histone acetylation (lane 2 and 5, Figure 6). In a separate experiment, the cells were treated for 1 
hour with SAHA before the HAT inhibitors were added and the cells were treated with SAHA 
and the HAT inhibitor for 20 h (lane 3 and 6, Figure 6). Treatment with SAHA and 14 did not 
decrease the acetylation level compared to SAHA treated cells (lane 3, Figure 6). The acetylation 
level decreased in cells that were treated with SAHA and the known HAT inhibitor anacardic 
acid21 compared to SAHA treated cells (lane 6, Figure 6). The quantification results show that 5 -
chloroisothiazolone 14 does not effectively down-regulate acetylation of histone H4 in HEP G2 
cells under the applied conditions in contrast to the known HAT inhibitor anacardic acid. The 
lack of inhibition might be explained by a lack of cellular permeability or metabolic stability. 
Alternatively, the inhibition of the HAT PCAF might be compensated by other HATs that are not 
affected by 14. Furthermore, the cytotoxicity assay result shows that the treatment with the HAT 
inhibitor at concentration employed in the inhibition assay is not toxic to the cell.  
 
 
Figure 6. Cell-based studies on histone acetylation. HEP G2 cell were treated for 24 h with vehicle or HDAC 
and HAT inhibitors. The histones were extracted and blotted with an anti-acetyl H4 antibody (C). The loading 
was standardized based on a Coomassie staining on a separate blot (C). The data were quantified and shown in 
bar graphs (A and B). The bars represent the average of four independent experiments with their respective 
standard deviations. Lane 1 and 4 are histones from vehicle (DMSO dilution) treated cells. Lane 2 and 5 are 
cells that are treated with 10 M of the HDAC inhibitor SAHA. Lane 3 is histones from cell that were treated 
with 10 M SAHA and 10 M 14. Lane 6 is histones from cell that were treated with 10 M SAHA and 50 M 






































anacardic acid 14 
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Conclusion 
In conclusion, isothiazolones and 5-chloroisothiazolones react with thiolates by disulfide 
formation and cleavage of the nitrogen-sulfur bond. The crystal structures illustrate the aromatic 
character of isothiazolones. Whereas this aromaticity provides stability to the compounds, the 
weak sulfur-nitrogen bond allows a fast reaction with sulfur nucleophiles. Based on their 
reactivity, 5-chloroisothiazolones and isothiazolones inhibit thiol containing enzymes, such as the 
cysteine protease cathepsin B and the HAT PCAF. Their potency depends on the substitution 
pattern. Selectivity for inhibition of the HAT PCAF was observed for N-aryl substituted 
isothiazolone 9. The most potent HAT inhibitor 14 did not effectively downregulate histone 
acetylation in cell-based studies under the applied conditions. Enzyme kinetics and mass 
spectrometry indicate covalent binding of 5-chloroisothiazolone 5 to the active site thiol and/or to 
another surface exposed cysteine of cathepsin B. The fact that isothiazolones and 5-
chloroisothiazolones react with thiolates to form disulfides makes them excellent candidates for 
activity-based protein profiling of thiol-containing enzymes.  
Experimental 
General 
All reagents and solvents were obtained from commercial suppliers (Sigma-Aldrich, Acros 
Organics) and were used without further purification. CH2Cl2 was distilled over CaH2 before use. 
Merck silica gel 60 F254 plates were used for analytical thin layer chromatography (TLC) and 
spots were detected by UV light, or stained using KMNO4 or ninhydrin solution. Column 
chromatography was performed with MP Ecochrom silica gel 32-63, 60Ǻ using the flash 
chromatography technique. 1H (200 MHz) and 13C (50 MHz) NMR spectra were recorded on a 
Varian Gemini 200 spectrometer in CDCl3 unless otherwise specified. 
1H chemical shift are 
reported in ppm (δ) downfield from internal standard tetramethylsilane (TMS). 13C NMR spectra 
were recorded using the attached proton test (APT) and chemical shifts are relative to the solvent. 
Melting points were determined using an Electrocome digital melting point measurement 
apparatus. High-resolution mass spectra (HR-MS) were recorded using a flow injection method 
on a LTQ-Orbitrap XL mass spectrometer (Thermo Electron, Bremen, Germany) with a 
resolution of 60,000 at m/z 400. Protonated testosterone (lock mass m/z = 289.2162) was used for 
internal recalibration in real time.  
 The enzyme cathepsin B (human liver) and cathepsin Substrate III, Fluorogenic (Z-RR-AMC) 
was obtained from Calbiochem. 7-amino 4-methyl coumarine was obtained from Sigma. HEP G2 
cells were purchased from the American Type Culture Collection and cultured in Dulbecco's modified 
Eagle's medium (GIBCO, cat. 41966) containing 10% fetal bovine serum (PAA, cat. A15-151) and 
     115     
 
Isothiazolones; thiol-reactive inhibitors of  
cysteine protease cathepsin B and histone acetyl transferase 
1% penicillin and 1% streptomycin (GIBCO, cat. 15140) at 37 ºC, in 5% CO2. Cells were not cultured 
beyond 50 passages. 
Organic Synthesis 
Synthetic procedure 1 
Isothiazolones and 5-chloroisothiazolones were synthesized according to the procedure described 
by Dekker et al.15, 16. The 3,3’-dithiobis-propionamide was dissolved in dry CH2Cl2 at 0 oC and 
SO2Cl2 was added dropwise to the solution. The mixture was stirred at 0 °C for 2 hours. The 
mixture was washed with water (2 times) and brine (1 time), dried using Na 2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by column chromatography. 
 
5-chloro-2-phenylisothiazol-3(2H)-one (5) 
The product was obtained using synthetic procedure 1. Purification was performed using column 
chromatography with hexane/EtOAc 10:1 (v/v) as eluent. Yield 43%. Off-white solid. Crystals 
(colorless needles) for X-ray diffraction were obtained by crystallization from EtOAc:hexanes 1:1 
at 4 oC over 2 days. Mp = 118.4 °C. Rf = 0.52 (hexane:EtOAc 1:1). 
1H NMR (200 MHz, CDCl3) δ 
6.35 (s, 1H), 7.27-7.55 (m, 5H). 13C NMR (50 MHz CDCl3) δ 114.9, 124.8, 127.8, 129.5, 135.7, 
146.4, 165.4. MS (ESI) m/z 211.9 [M+H]
+
. HRMS (m/z) 211.9931 [M+H]
+




2-phenylisothiazol-3(2H)-one (1)  
After elution of product 5 product 1 was eluted from the column with hexane/EtOAc 1:1 (v/v) as 
eluent. Yield 29%. Off-white solid. Crystals (colorless platelets) for X-ray diffraction were 
obtained by crystallization from EtOAc:hexanes 3:4 at 4oC over 2 days. Mp = 92.8 °C. Rf = 0.16 
(hexane:EtOAc 1:1). 1H NMR (200 MHz, CDCl3) δ 6.32 (d, J = 6.2 Hz, 1H), 7.29-7.61 (m, 5H), 
8.18 (d, J = 6.5 Hz). 13C NMR (50 MHz CDCl3) δ 114.8, 124.8, 127.5, 129.4, 136.5, 139.8, 167.6. 
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5-chloro-2-(2-chloro-4,5-dimethoxyphenethyl)isothiazol-3(2H)-one (11)  
The product was obtained using synthetic procedure 1. Purification was performed using column 
chromatography with hexane/EtOAc 1:1 (v/v) as eluent. Yield 6%. White-yellow solid. Mp = 
108.5 °C. Rf = 0.20 (hexane:EtOAc 1:1). 
1H NMR (200 MHz, CDCl3) δ 3.04 (t, J = 7.0 Hz, 2H), 
3.82 (s, 3H), 3.86 (s, 3H), 3,95 (t, J = 7.0 Hz, 2H), 6.25 (s, 1H), 6.68 (s, 1H), 6.86 (s, 1H). 13C 
NMR (50 MHz CDCl3) δ 32.8, 43.3, 56.0, 112.5, 113.2, 114.3, 124.9, 126.4, 145.8, 147.8, 148.5, 
166.6. MS (ESI) m/z  334.3 [M+H]+. HRMS (m/z) 334.0065 [M+H]+, calcd 334.0066 
C13H14Cl2NO3S
+; (m/z) 119.0521 [M-C3H1ClNO2S]
+
, calcd 119.0520 C10H12ClO2
+. 
Synthetic procedure 2 
The 5-chloroisothiazolone (1 mmol) was dissolved in 2 mL CH2Cl2 and cooled to 0 °C. A 0.5 M 
propane-1-thiol solution in CH2Cl2 (1 mL) was added, and the progress of reaction was followed 
by TLC. A 0.5 M triethylamine (TEA) solution in CH2Cl2 (1 mL) was added to the mixture and 
reacted for another 30 minutes. The mixture was diluted with 20 mL of CH2Cl2 and washed with 
H2O (2 times 50 mL), brine (1 times 50 mL) and dried using Na2SO4. 
 
N-phenyl-3-(propyldisulfanyl)acrylamide (3)  
The product was obtained using synthetic procedure 2. Purification was performed using column 
chromatography with hexane/EtOAc 15:1 (v/v) as eluent. Yield 21%. White solid. R f = 0.70 
(hexane:EtOAc 1:1). 1H NMR (200 MHz, CD3CN) δ 1.03 (t, J = 7.4 Hz, 3H), 1.72 (m, 2H), 2.80 
(t, J = 7.2 Hz, 2H), 6.50 (d, J = 14.1 Hz, 1H), 7.09 (t, J = 7.4 Hz, 1H), 7.32 (t, J = 7.5 Hz, 2H) 
7.51-7.64 (m, 3H), 8.50 (br. 1H). 13C NMR (50 MHz CD3CN) δ 13.2, 23.2, 40.4, 120.4, 121.2, 
124.7, 129.8, 139.9, 142.9, 163.0. MS (ESI) m/z 254.1 [M+H]
+




+; (m/z) 178.0323 [M-C3H7S]
+
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Methyl 6-(3-(propyldisulfanyl)acrylamido)hexanoate (4) 
The product was obtained using synthetic procedure 2. Purification was performed using column 
chromatography with hexane/EtOAc 3:1 (v/v) as eluent. Yield 24%. White solid. R f = 0.36 
(hexane:EtOAc 1:1). 1H NMR (200 MHz, CD3CN) δ 0.98 (t, J = 7.2 Hz, 3H), 1.25-1.70 (m, 10H), 
2.77 (t, J = 7.2 Hz, 2H), 3.10-3.21 (m, 2H), 3.60 (s, 3H), 5.86 (d, J = 9.7 Hz, 1H), 6.59 (br. 1H), 
6.99 (d, J = 9.7 Hz, 1H). 13C NMR (50 MHz CD3CN) δ 12.2, 22.1, 24.3, 26.0, 28.9, 33.4, 38.6, 
41.0, 50.9, 118.0, 152.1, 165.9, 173.8. MS (ESI) m/z 306.0 [M+H]
+
. HRMS (m/z) 328.1009 
[M+Na]
+
, calcd 328.1012 C13H23NNaO3S2
+; (m/z) 306.1191 [M+H]
+
, calcd 306.1192 
C13H24NO3S2
+; (m/z) 230.0844 [M-C3H7S]
+
, calcd 230.0845 C10H16NO3S
+. 
 
N-phenyl-3-(propyldisulfanyl)-3-chloro-acrylamide (7)  
The product was obtained using synthetic procedure 2. Purification was performed using column 
chromatography with hexane/EtOAc 20:1 (v/v) as eluent. Yield 60%. White solid. R f = 0.67 
(hexane:EtOAc 1:1). 1H NMR (200 MHz, CD3CN) δ 0.99 (t, J = 7.4 Hz, 3H), 1.72 (m, 2H), 2.79 
(t, J = 7.2 Hz, 2H), 6.56 (s, 1H), 7.10 (t, J = 7.4 Hz, 1H), 7.33 (m, 2H) 7.58 (d, J = 7.6 Hz, 2H), 
8.50 (br. 1H). 13C NMR (50 MHz CD3CN) δ 13.2, 22.7, 42.8, 120.3, 122.2, 125.0, 129.8, 139.4, 
151.4, 163.3. MS (ESI) m/z 288.1 [M+H]
+
. HRMS (m/z) 288.0277 [M+H]
+
, calcd 288.0278 
C12H15ClNOS2
+; (m/z) 211.9931 [M- C3H7S]
+
, calcd 211.9931 C9H7ClNOS
+. 
 
phenyl-3-(propyldisulfanyl)-3-hydroxy-acrylamide (8)  
The product was obtained using synthetic procedure 2 with overnight reaction time. Purification 
was performed using colomn chromatography with hexane/EtOAc 5:1 (v/v) as eluent. Yield 30%. 
Yellow solid. Rf = 0.57 (hexane:EtOAc 1:1). 
1H NMR (200 MHz, CDCl3) δ 0.97 (m, 3H), 1.63 
(m, 2H), 2.67 (m, 2H), 7.22 (m, 1H), 7.25 (m, 2H), 7.50 (m, 3H), 8.73 (br. 1H). 13C NMR (50 
MHz CDCl3) δ 13.7, 23.3, 36.7, 37.1, 119.6, 119.7, 120.6, 120.7, 124.4, 125.4, 127.1, 129.2, 
129.3, 130.8, 136.9, 137.1, 138.0, 157.4, 163.5. MS (ESI) m/z 270.1 [M+H]+. 
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Cathepsin B inhibition 
Enzyme inhibition was measured by the residual enzyme activity after 15 min incubation with the 
inhibitor. The enzyme activity was determined by conversion of cathepsin B substrate Cbz-Arg-
Arg-AMC.18 The conversion rate was determined by fluorescence detection of 7-amino 4-methyl 
coumarine with 1 min intervals over 15 min at 25oC. Detection was performed with an excitation 
wavelength of 355 nm and an emission wavelength of 450 nm. The cathepsin B enzyme (0.5 
mg/ml) was diluted 1:4000 with cathepsin B assay buffer (100 mM Na2HPO4.2H2O; 1.25 mM 
EDTA.2Na; pH=6.8) containing 100 mM DTT. The inhibitor (10 mM in CH3CN) was diluted 
with cathepsin B assay buffer containing 1% (v/v) Triton-X to the desired concentration. 
Calculations were performed with Excel 2003 and non-linear curve fitting was performed with 
the Origin 7 software. 
Michaelis Menten enzyme kinetics 
The enzyme kinetic experiments were performed using the same assay setup as used for the IC50 
determinations. Various concentrations of fluorogenic substrate Cbz-Arg-Arg-AMC (7.81-1000 
µM) were added to the enzyme. The fluorescence values were converted to concentrations using a 
7-amino 4-methyl coumarine calibration curve (0.78-25 µM). The concentration change over time 
is the reaction velocity (v) that is plotted against the substrate concentration (s) in Figure 3. The 
experiments were performed in triplicate and the average triplicate values and their standard 
deviations are plotted. Calculations were performed with Excel 2003 and non-linear curve fitting 
with equation 1 was performed with the Origin 7 software. The results are shown in Table 3.  
Mass spectroscopy 
Inhibitor 5 (50 mM) and cathepsin B (0.25 mg/mL) were incubated in phosphate buffer (100 mM 
Na2HPO4.2H2O; 1.25 mM EDTA.2Na; pH = 6.8) for 20 min at room temperature. This mixture 
was mixed 1 to 1 with the sinapinic acid matrix and subjected to MALDI TOF mass 
spectroscopy.  
Western blot on histone acetylation 
HEP G2 cells were seeded (10,000 cells) in T-175 flasks and cultured until 50% confluence. 
Subsequently, the cells were treated with HDAC and HAT inhibitors or control solutions. The 
inhibitors were diluted from stock solutions (10 mM) in DMSO. The residual DMSO at the applied 
concentrations did not have an effect on histone acetylation. Cells were treated with phosphate buffer 
saline pH 7.4 (PBS) as control or with SAHA (10 µM) for 20 hours. The HAT inhibitors were added 
to cells that were pretreated with SAHA (10 µM) for 1 hour after which the cells were cultured for 20 
hours in medium with SAHA and the HAT inhibitor. Anacardic acid was applied at 50 µM and 5-
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chloroisothiazolone 14 was applied at 10 µM. The viability of the cells was more than 70% at the 
applied concentrations as determined by a MTT assay. 
 The histones were extracted using the following procedure. Cells were trypsinized for 10 minutes 
at 37 ºC and washed twice with ice-cold PBS. The PBS was replaced with 5 mL ice-cold lysis buffer 
(10mM Tris, 50 mM sodium bisulfite, 10 mM MgCl2, 8.6% sucrose, 1% Triton-X, pH 6.5) and the 
cells were sonicated at 0 oC (3 times 15 sec with 15 sec intervals) Subsequently the suspension was 
centrifuged (10 min 12 000 rcf, 4 oC) and the pellet was washed three times with ice-cold lysis buffer. 
The pellet was washed once in washing buffer (10 mM Tris, 10 mM EDTA, pH 7.4) and resuspended 
in 400 μL ice-cold water. H2SO4 was added to a final concentration of 0.4 M and samples were 
incubated for one hour at 0 oC and centrifuged (10 min, 12 000 rcf, 4 ºC). The supernatant was then 
transferred to a vial with five volumes acetone and incubated overnight at -20 ºC. The suspension was 
centrifuged (10 min, 16 000 rcf, 4 ºC), the supernatant was discarded and the pellet was air-dried at 
room temperature. The pellets were then resuspended in 500 μL demi water.  
 The protein concentrations of samples were determined using the BioRad Protein Assay, with BSA 
as calibration. Samples of 6.25 μg of protein from each extract were loaded on polyacrylamide gels 
(SDS-PAGE). Acidic samples were neutralized using 100 mM Tris-buffer pH 8.8 and if necessary, 
100 mM sodium hydroxide until the laemmli buffer regained its blue coloration. Samples of 20 μL 
were then run on 12.5% polyacrylamide gels at 70 volts through the stacking gel and 110 volts 
through the resolving gel before blotting onto PVDF membrane for two hours at 200 mA. The PVDF 
membrane was stained using Coomassie blue and destained using destaining solution (40% methanol 
and 10% acetic acid in water) for 30 minutes at room temperature. The Coomassie-stained membrane 
was used as a loading control for each sample. Another membrane with the same sample was blocked 
using 10 mL 5% BSA in PBS. The membrane was washed (3 times, 5 min, room temp) with PBS 
containing 0.05% v/v Tween 20 (PBS-T). The membrane was stained with 10 mL 1:2000 anti-acetyl 
H4 (Millipore 06-598) in PBS-T. The membrane was washed (3 times, 5 min, room temp.) with PBS-
T. The membrane was incubated with 10 mL 1:1000 HRP-conjugated swine anti-rabbit antibody 
(DakoCytomation, cat. P0217) and washed with PBS-T (3 times, 5 min, room temp.) Staining was 
performed using AEC (Sigma-Aldrich, cat. AEC101-1KT) according to the manufacturer's 
instructions. The membrane was exposed to this solution until bands appeared and the reaction was 
stopped by washing the membrane with demi water. The bands were scanned using a Bio-Rad GS-
710 densitometer with the blue filter setting and quantified using the open source software Image J. 
The antibody-based quantifications were normalized against the total protein as measured by 
Coomassie staining. The average and standard-deviations of four independent experiments are 
reported (Figure 6). 
 120 
 
Isothiazolones; thiol-reactive inhibitors of  
cysteine protease cathepsin B and histone acetyl transferase 
Cytotoxicity assay 
Cells (7,500) were seeded in DMEM medium (95 µL) in 96 well plates. In the blank determination no 
cells were seeded. After 24 hours different concentrations of the compounds were added in PBS (5 
μL). In the positive control no compound was added. Each plate was centrifuged briefly before 
returning to incubation. Determinations were performed in 8-fold on each plate. After 48 hours, cells 
were treated with filter-sterilized MTT solution (20 μL, 5 mg.ml-1) per well, followed by brief 
centrifugation and three hours incubation at 37 ºC, 5% CO2. The medium was removed and 4 mM 
HCl, 0.1% v/v Triton-X in isopropanol (150 μL) was added. The plate was shaken for 15 minutes and 
absorbance read at 550 nm on a ThermoMax microplate reader. 
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